Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway
Year: 2015
Type: article
Abstract: Pericytes play a critical role in the cerebrovasculature within the CNS. These small contractile cells produce large quantities of apolipoprotein E (apoE) whose isoforms influence cerebrovascular functions and determine the genetic risk for Alzheimer disease. Despite extensive studies on astrocyte-secreted apoE, which supports synapses by transporting cholesterol to neurons, the biochemical properties and function of apoE secreted by pericytes are not clear. Because pericytes mediate important functions in the CNS, including the initiation of glial scar formation, angiogenesis, and maintenance of the blood-brain barrier, we investigated the potential role of apoE in pericyte mobility. We found that knockdown of apoE expression significantly accelerates pericyte migration, an effect that can be rescued by exogenous apoE3, but not apoE4, a risk factor for Alzheimer disease. ApoE-regulated migration of pericytes also requires the function of the low-density lipoprotein receptor-related protein 1 (LRP1), a major apoE receptor in the brain that is abundantly expressed in pericytes. Because apoE-knockdown also leads to enhanced cell adhesion, we investigated the role of apoE in the regulation of the actin cytoskeleton. Interestingly, we found that the levels of active RhoA are increased significantly in apoE knockdown pericytes and that RhoA inhibitors blocked pericyte migration. Taken together, our results suggest that apoE has an intrinsic role in pericyte mobility, which is vital in maintaining cerebrovascular function. These findings provide novel insights into the role of apoE in the cerebrovascular system. Background: Pericytes are a major cerebrovasculature component, producing abundant apolipoprotein E (apoE). Results: Deletion of apoE accelerates pericyte migration and adhesion by increasing RhoA activity. The effects are reversed by exogenous apoE3 but not apoE4. Conclusion: ApoE suppresses pericyte mobility in a RhoA-mediated manner. Significance: Pericyte-derived apoE regulates cell mobility and can be explored as a target for neurovascular disease therapy.
Source: Journal of Biological Chemistry
Institutions: Mayo Clinic, Mayo Clinic in Florida
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: ApoE Receptor Biology and Neurodegeneration, ApoE pathway in cerebrovascular Aβ clearance in Alzheimer's disease, ApoE isoform-specific therapy for Alzheimer disease, ApoE isoform-specific therapy for Alzheimer disease, ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal), Regional, Synaptic, Cellular Modulation of Abeta Metabolism, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W2016605174
